Add BrightSurf on Google Email

How much do Americans spend on GLP-1 medications? VCU medical students measure drug affordability

A study by VCU medical students found that nearly 1 in 5 GLP-1 users spent at least 10% of their household income on the medications, while 7% of patients spent an average of 7% of their household income annually. The researchers emphasize the need for solutions to make GLP-1 medications more affordable, particularly among uninsured an...

SourceVirginia Commonwealth University·JournalJournal of General Internal Medicine·DateSep 28, 2026

Nasal spray brings pain relief for children treated in the emergency department

A nasal spray treatment has shown to provide rapid and effective pain relief for children in emergency departments, with 86.2% of children experiencing reduced pain 30 minutes after treatment. The treatment was well-tolerated with mild side effects, offering a simple and effective option for treating children in the emergency department.

Older Americans are taking more medications, with 1 in 5 at risk for a major drug interaction

A recent USC-led study reveals that over 1 in 5 older adults are at risk for major drug interactions, despite a decline in their prevalence. Polypharmacy and dietary supplement polypharmacy have increased, with antidepressants, statins, and antiplatelet therapies being the most commonly used medications involved in these regimens.

SourceUniversity of Southern California·JournalJAMA·TypeObservational study·DateSep 24, 2026

Microplastics may help antibiotic resistance travel farther through livestock waste

A new review suggests that microplastics can act as mobile carriers for antibiotics and antibiotic resistance genes, creating hotspots where resistance can persist and spread. The review calls for integrated treatment methods to control microplastics, antibiotics, and resistance genes.

SourceShenyang Agricultural University Collaborative Journals·JournalAgricultural Ecology and Environment·TypeLiterature review·DateSep 17, 2026

Efficacy and safety of semaglutide according to frailty status

A recent study found semaglutide to be effective in improving various clinical outcomes in patients with frailty, with greater benefits observed in those with higher frailty indices. The medication demonstrated a positive impact on health-related quality of life, highlighting its potential as a treatment option for this population.

SourceJAMA Network·JournalJAMA Cardiology·DateSep 16, 2026

The Lancet: New US Medicare pricing policies could reshape global pharmaceutical markets, potentially driving up prices and delaying medicine launches worldwide, study suggests

A new US Medicare pricing policy could reshape global pharmaceutical markets, potentially driving up prices and delaying medicine launches worldwide. The study estimates that Medicare could save $5.2 billion under its initial phase, with savings rising to $21 billion if expanded to all Medicare beneficiaries.

SourceThe Lancet·JournalThe Lancet·TypeComputational simulation/modeling·DateSep 13, 2026

Protein clues in the blood may help children avoid diseases later in life

Researchers have identified early signs of cardiovascular-kidney-metabolic disease (CKMD) in children as young as 8 years old that can be reversed with a new class of weight loss drugs. The study found that levels of certain disease-associated proteins in children decline in response to therapy with semaglutide, a GLP-1 receptor agonis...

SourceVanderbilt University Medical Center·JournalNature Metabolism·DateSep 11, 2026

Loberamisal for acute ischemic stroke

A study published in JAMA found that intravenous loberamisal increased the proportion of patients with acute ischemic stroke achieving full functional outcomes at 90 days. The treatment resulted in a higher proportion of patients regaining full functional abilities compared to placebo.

SourceJAMA Network·JournalJAMA·DateSep 10, 2026

Weight loss injections and pregnancy – new guidelines support safe decision making

Weight loss injections can impact reproductive health, and a new study provides evidence-based guidelines for families and health professionals. The guidelines recommend that incretin-based medication therapy should not be deliberately continued throughout pregnancy, but women who used the injections without realizing they were pregnan...

SourceUniversity of Plymouth·JournalObesity Reviews·TypeSystematic review·DateSep 9, 2026

Paracetamol use during pregnancy is linked to changed reproductive development in daughters

Researchers found that girls whose mothers took paracetamol during pregnancy had smaller ovaries, fewer ovarian follicles, and lower levels of reproductive hormones at three months old. The study, published in Human Reproduction Open, suggests that foetal exposure to paracetamol may affect reproductive development, but the findings do ...

SourceEuropean Society of Human Reproduction and Embryology·JournalHuman Reproduction Open·TypeObservational study·DateSep 8, 2026

River drinking water sources may face greater antibiotic resistance risks than reservoirs, study finds

A study of 13 drinking water sources in China's Poyang Lake region reveals that river-type sources carry higher risks from antibiotics and resistant bacteria than reservoir-type sources. The findings highlight the importance of considering water source type when designing monitoring and pollution-control strategies.

SourceShenyang Agricultural University Collaborative Journals·JournalBiocontaminant·TypeExperimental study·DateSep 8, 2026

Blood-thinning medication linked to slower cognitive decline

A study from Karolinska Institutet found that people treated with modern NOAC blood-thinning medicines experienced a slower rate of cognitive decline compared to those receiving warfarin or no anticoagulant treatment. This was associated with lower risk of other health problems, including death, stroke, and fractures.

SourceKarolinska Institutet·JournalEuropean Heart Journal·TypeObservational study·DateAug 12, 2026

Aston University research sheds more light on the antimicrobial properties of mānuka honey

New research at Aston University shows that mānuka honey's effectiveness against disease-causing bacteria cannot be attributed solely to its sugar content and methylglyoxal levels. The study identified additional bioactive compounds responsible for the antimicrobial activity, which may lead to the development of more effective honey-de...

SourceAston University·JournalMicrobiology·TypeExperimental study·DateAug 11, 2026

Osimertinib with or without chemotherapy in advanced non–small cell lung cancer with EGFR and concurrent TP53 mutations

A randomized phase 3 study found that first-line osimertinib plus chemotherapy significantly improved median progression-free survival compared to osimertinib alone in patients with advanced non–small cell lung cancer (NSCLC) and concurrent EGFR and TP53 mutations. This study provides evidence for incorporating TP53-based molecular ris...

SourceJAMA Network·JournalJAMA·DateAug 10, 2026

Erectile dysfunction drug used to treat enlarged prostate symptoms may raise glaucoma risk

A comparative study found that men prescribed tadalafil (Cialis) for enlarged prostate symptoms are at a higher risk of developing glaucoma and ocular hypertension. The researchers suggest that these patients should have their eye health monitored closely, especially those with existing high blood pressure or family history of glaucoma.

SourceBMJ Group·JournalBritish Journal of Ophthalmology·TypeObservational study·DateAug 4, 2026

After anesthesia

Researchers found that female mice's microglia form prolonged contacts with neurons during recovery, leading to synaptic remodeling and plasticity. This phenomenon was not observed in male mice, highlighting differences in brain recovery processes between sexes.

SourceInstitute of Science and Technology Austria·JournalScience Advances·TypeExperimental study·DateJul 31, 2026

Cancer medicine approvals in the US

A cross-sectional study examines trends in US FDA-approved cancer medicines for adult solid tumors between 2006 and 2025. The analysis reveals significant increases in approvals, particularly for original indication approvals.

SourceJAMA Network·JournalJAMA·DateJul 30, 2026

New study identifies behaviours influencing prescribing decisions for new medicines in neurodegenerative disease

A new pan-European study identified the psychological and contextual factors that shape decision-making among healthcare professionals. The findings provide important insights into how behaviour change frameworks could support the uptake of new treatments, with the strongest lever being to shift intention to prescribe.

SourceAston University·JournalPLOS One·TypeMeta-analysis·DateJul 28, 2026

Topline results from LiBBY trial show THC/CBD combination significantly reduces agitation for people with dementia at end of life

A Phase 2 clinical trial shows that a THC/CBD combination significantly reduces agitation in hospice-eligible people with dementia. The study, conducted across multiple US sites, achieved its primary and key secondary endpoints, demonstrating the efficacy of this treatment approach for end-of-life agitation.

High-resolution map reveals where veterinary antibiotics enter China’s environment

A new study has developed a high-resolution inventory of veterinary antibiotic emissions across China, tracking emissions from livestock and aquaculture into soil, freshwater, and seawater. The inventory estimated that approximately 23,110 tonnes of veterinary antibiotics were released into China's environment in 2020.